• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 药品评价-循证医学研究 • 上一篇    下一篇

我国药品说明书中孕妇及哺乳期妇女用药标示情况分析

杨佳卉,唐佳,张雅婷,吴琼慧,田金徽   

  1. 兰州大学循证医学中心,兰州大学基础医学院,,,,
  • 收稿日期:2016-07-18 修回日期:2016-07-18 出版日期:2016-08-25 发布日期:2016-08-25
  • 基金资助:
    ]甘肃省循证医学与临床转化重点实验室开放基金;兰州大学中央高校基本科研业务专项资金资助(lzujbky-2015-170;lzujbky-2014-18)

Analysis of the labeling contents of drug instructions for pregnant women and lactating women in China

  1. Evidence-based Medicine Center,School of Basic Medical Sciences,Lanzhou University,Gansu Lanzhou,Evidence-based Medicine Center,School of Basic Medical Sciences,Lanzhou University,Gansu Lanzhou,Evidence-based Medicine Center,School of Basic Medical Scienc
  • Received:2016-07-18 Revised:2016-07-18 Online:2016-08-25 Published:2016-08-25

摘要: 目的:采用Meta分析方法分析我国药品说明书中孕妇及哺乳期妇女用药标示情况,为完善与规范我国药品说明书中孕妇及哺乳期妇女用药内容的标示。方法:全面、系统检索中国生物医学文献数据库、中国知网、万方数据库中有关我国药品说明书中孕妇及哺乳期妇女用药标示情况的研究,采用STATA13.0软件对相关指标进行合并分析,并对药物不同剂型等指标进行亚组分析。结果:共纳入13个研究,总样本量为5895。Meta分析结果显示,药品说明书中孕妇及哺乳期妇女用药相关项标示中,标注为 “禁用”的标注率为 25%,无标注者为23%。【药代药动学】、【用法用量】、【注意事项】(包括禁忌)未标注率分别高达82%、84%和63%。【药物相互作用】标注“尚无资料”者占本研究统计的100%。结论:我国部分药品说明书中孕妇及哺乳期妇女用药内容存在缺项或标示不准确现象,严重影响孕妇及哺乳期妇女用药安全。

Abstract: [] Objective: To analyze the existing problems of the labeling contents of drug instructions for pregnant women and lactating women in China by meat analysis,in order to improve and standardize contents of labeling contents.Methods: CBM, CNKI and WanFang database were searched,the studies of labeling contents of drug instructions for pregnant women and lactating women were included. The related data were analyzed by STATA 13.0 software,at the same time,subgroup analysis was performed by dosage forms.Results: Thirteen studies were included with a total sample size of 5895. The Meta-analysis showed that for all related items, the rate of the usage and dosage such as annotations was forbidden to use is 25%, the rate of it without annotation is 23%. The rates of pharmacokinetics, usage and dosage, precautions (contraindications) without annotation are 82%,84% and 63%. The rate of drug interactions with no information of pregnant and lactating women using is 100%.Conclusion:The labeling contents drug instructions for pregnant women and lactating women in China were missing or insufficient, which may be affect the safety of using medicines for them.